Výsledky vyhledávání - "Brenda Staehle"

Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years

Autor: Mary L. Kumar, Leonard P. Rome, Chitra Dinakar, Judy K. Whitwell, Candice E. Johnson, William Hurni, Brenda Staehle, David R. Nalin

Publikováno v: The Pediatric Infectious Disease Journal. 15:687-692

Background. Since 1989 the American Academy of Pediatrics and the ACIP have recommended a second dose of measles-mumps-rubella vaccine (M-M-R®-II) at either school entry or age 11 to 13 years. Unfortunately few studies are available to compare respo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7bd0aa59ffe92bb234b037474b1b687
https://doi.org/10.1097/00006454-199608000-00010

Zobrazit plný text záznamu

Safety and Cellular and Humoral Immune Responses of a Booster Dose of Varicella Vaccine 6 Years after Primary Immunization

Autor: A Ngai, Allan M. Arbeter, Mary L. Kumar, Keith S. Reisinger, Henry H. Bernstein, C. Jo White, Mark M. Blatter, Barbara Watson, Stephen A. Chartrand, Edward P. Rothstein, Dennis A. Clements, Ann M. Arvin, Brenda Staehle, Stuart E. Starr

Publikováno v: Journal of Infectious Diseases. 172:217-219

Four hundred nineteen children and adolescents immunized with live varicella vaccine 4-6 years earlier were enrolled in a study to evaluate the safety and immune response to a booster dose containing approximately 3300 pfu of virus. Of the subjects,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45cffd9ea20cc7d48ca2b12abd5a79b9
https://doi.org/10.1093/infdis/172.1.217

Zobrazit plný text záznamu

Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy children

Autor: Christina Y. Chan, Barbara J. Kuter, Kathleen Ensor, Marilyn Waters, Joseph F. Heyse, Steven Black, Brenda Staehle, Ivan H. Chan, Henry R. Shinefield, S J Rupert Vessey, Karen M. Kaplan, Holly Matthews, Shu Li, Tama Adelman

Publikováno v: The Pediatric infectious disease journal. 21(6)

Background Administration of M-M-R II (Measles, Mumps and Rubella Virus Vaccine, Live) and VARIVAX [Varicella Virus Vaccine Live (Oka/Merck)] given concomitantly at separate injection sites during the same office visit could increase vaccine complian

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::733d1f3a41a52e26145335f485075f9b
https://pubmed.ncbi.nlm.nih.gov/12182381

Zobrazit plný text záznamu

Safety, tolerability and immunogenicity of concomitant injections in separate locations of M-M-R II, VARIVAX and TETRAMUNE in healthy children vs. concomitant injections of M-M-R II and TETRAMUNE followed six weeks later by VARIVAX

Autor: Tama Adelman, S R Bird, C J White, Barbara J. Kuter, Steven Black, Brenda Staehle, Holly Matthews, A Ngai, Kathleen Ensor, Henry R. Shinefield

Publikováno v: The Pediatric infectious disease journal. 17(11)

Objectives and study design. The primary objectives of this study were to compare immunologic responses, antibody persistence, safety and varicella breakthrough rates when VARIVAX® (varicella vaccine) is given at the same time as M-M-R® II (measles

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::475832c8e6ef871e63090a88934c7600
https://pubmed.ncbi.nlm.nih.gov/9849978

Zobrazit plný text záznamu

Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children

Autor: Paul M. Keller, Iksung Cho, Barbara J. Kuter, Brenda Staehle, Barbara Watson, Holly Matthews, Nancy Cyanovich, C J White, Ann M. Arvin, A Ngai

Publikováno v: The Pediatric infectious disease journal. 15(1)

To compare the safety and immunogenicity of a one- vs. two-dose regimen of Oka/Merck varicella vaccine in approximately 2000 healthy children 12 months to 12 years of age.Subjects with a negative history of varicella were randomized to receive either

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::072056d40be751a2802b7558ff3caf20
https://pubmed.ncbi.nlm.nih.gov/8684876

Zobrazit plný text záznamu

SAFETY AND IMMUNOGENICITY OF CONCOMITANT SEPARATE ADMINISTRATION OF MMRII, TETRAMUNE (WYETH LEDERLE DPT & HbOC) AND VARIVAX (OKA/MERCK VARICELLA VACCINE) VS. CONCOMITANT INJECTIONS OF MMRII AND TETRAMUNE• 660

Autor: Hervey Froehlich, Randy Bergen, Allan Lavetter, James Glauber, Angela Ngai, Brenda Staehle, Steve Black, Tama Adelman, Pius A. Morozumi, Jo White, Kathleen Ensor, Henry R. Shinefield, Robert Kremers, Garwin Soe

Publikováno v: Pediatric Research. 39:113-113

Healthy children (N=609) 12 months to 23 months old were randomly assigned to one group(A) receiving MMRII, Tetramune and Varivax given separately and concomitantly and another group (B) receiving MMRII and Tetramune separately and concomitantly with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c833e801f6b4ddfd6120ca85d3070863
https://doi.org/10.1203/00006450-199604001-00682

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání